NO20014120L - Meioseaktiverende sterol öker implantasjonsgrad - Google Patents

Meioseaktiverende sterol öker implantasjonsgrad

Info

Publication number
NO20014120L
NO20014120L NO20014120A NO20014120A NO20014120L NO 20014120 L NO20014120 L NO 20014120L NO 20014120 A NO20014120 A NO 20014120A NO 20014120 A NO20014120 A NO 20014120A NO 20014120 L NO20014120 L NO 20014120L
Authority
NO
Norway
Prior art keywords
meiosis
implantation rate
activating sterol
increases implantation
sterol increases
Prior art date
Application number
NO20014120A
Other languages
English (en)
Other versions
NO20014120D0 (no
Inventor
Claus Yding Andersen
Anne Grete Byskov
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20014120D0 publication Critical patent/NO20014120D0/no
Publication of NO20014120L publication Critical patent/NO20014120L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20014120A 1999-02-26 2001-08-24 Meioseaktiverende sterol öker implantasjonsgrad NO20014120L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900273 1999-02-26
PCT/DK2000/000080 WO2000052142A2 (en) 1999-02-26 2000-02-25 Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation

Publications (2)

Publication Number Publication Date
NO20014120D0 NO20014120D0 (no) 2001-08-24
NO20014120L true NO20014120L (no) 2001-10-25

Family

ID=8091693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014120A NO20014120L (no) 1999-02-26 2001-08-24 Meioseaktiverende sterol öker implantasjonsgrad

Country Status (16)

Country Link
US (2) US20020042927A1 (no)
EP (1) EP1157096A2 (no)
JP (1) JP2002537801A (no)
KR (1) KR20020013505A (no)
CN (1) CN1341147A (no)
AU (1) AU2659200A (no)
BR (1) BR0008536A (no)
CA (1) CA2365225A1 (no)
CZ (1) CZ20012671A3 (no)
HU (1) HUP0200201A3 (no)
IL (1) IL144529A0 (no)
MX (1) MXPA01008657A (no)
NO (1) NO20014120L (no)
PL (1) PL350222A1 (no)
WO (1) WO2000052142A2 (no)
ZA (1) ZA200106101B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100757909B1 (ko) * 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ｉｖｆ를 위한 조성물
US20030153808A1 (en) * 2000-02-25 2003-08-14 Christa Hegele-Hartung Implantation rate using ff-mas
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
EP1216701A1 (en) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
CL2008003692A1 (es) * 2008-12-11 2011-05-13 Univ Pontificia Catolica Chile Fraccion de hormona foliculo estimulante (fsh) con un punto isoelectrico basico mayor a 4 y cadena de carbohidratos altamente ramificados y/o bisectadas; metodo de purificacion de dicha fraccion; composicion que comprende la fraccion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
AU717180B2 (en) * 1995-03-06 2000-03-16 Novo Nordisk A/S Stimulation of meiosis
AU2794100A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
JP2002537348A (ja) * 1999-02-24 2002-11-05 ノボ ノルディスク アクティーゼルスカブ 不妊症の治療
KR100757909B1 (ko) * 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ｉｖｆ를 위한 조성물
US6544166B1 (en) * 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility

Also Published As

Publication number Publication date
CA2365225A1 (en) 2000-09-08
US20050175976A1 (en) 2005-08-11
BR0008536A (pt) 2001-11-06
WO2000052142A2 (en) 2000-09-08
HUP0200201A3 (en) 2002-06-28
KR20020013505A (ko) 2002-02-20
ZA200106101B (en) 2002-02-04
CZ20012671A3 (cs) 2002-01-16
WO2000052142A3 (en) 2001-03-22
EP1157096A2 (en) 2001-11-28
CN1341147A (zh) 2002-03-20
IL144529A0 (en) 2002-05-23
JP2002537801A (ja) 2002-11-12
MXPA01008657A (es) 2003-06-24
PL350222A1 (en) 2002-11-18
US20020042927A1 (en) 2002-04-11
AU2659200A (en) 2000-09-21
NO20014120D0 (no) 2001-08-24
HUP0200201A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
ATE388677T1 (de) Zwischenwirbelimplantat
DE50010727D1 (de) Flächiges Implantat
DE50010295D1 (de) Zwischenwirbel-nucleus-prothese
DE60026125D1 (de) Intraokulares Implantat
DE50007243D1 (de) Säschar
DE60021217D1 (de) Ostomievorrichtung
FR2780269B1 (fr) Implant rachidien
DE60017816D1 (de) Herzschrittmacher
DE60017132D1 (de) Intraokulares implantat
DK1223887T3 (da) Implantatindstilling
DE60016600D1 (de) Herzschrittmacher
DE60016144D1 (de) Hörhilfegerät
DE59911113D1 (de) Herzschrittmacher
DE50011489D1 (de) Sägerät
DE29822563U1 (de) Implantat
DK1228666T3 (da) Høreapparat
NO20014120L (no) Meioseaktiverende sterol öker implantasjonsgrad
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
DE50009340D1 (de) Einstelleinrichtung
FR2798583B1 (fr) Implant cotyloidien
DE60013608D1 (de) Herzschrittmacher
FR2789570B1 (fr) Prothese cotyloidienne
ATE267555T1 (de) Prothesensystem
FR2797177B1 (fr) Implant intraoculaire precristallinien
DE60034671D1 (de) Implantatsystem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application